Gut microbiota correlates with energy gain from dietary fibre and appears to be associated with acute and chronic intestinal diseases  by Ukhanova, M. et al.
Gut microbiota correlates with energy gain from dietary ﬁbre and
appears to be associated with acute and chronic intestinal diseases
M. Ukhanova1, T. Culpepper1, D. Baer2, D. Gordon3, S. Kanahori3, J. Valentine4, J. Neu5, Y. Sun6, X. Wang1 and V. Mai1
1) Microbiology and Cell Science, Emerging Pathogens Institute, University of Florida, Gainesville, FL, 2) US Department of Agriculture, Agricultural Research
Service, Beltsville Human Nutrition Research Center, Beltsville, MD, USA, 3) Matsutani Chemical Industry Co. Ltd, Itami City, Hyogo, Japan, 4) Division of
Gastroenterology, Gainesville, FL, 5) Division of Pediatrics, Gainesville, FL and 6) ICBR University of Florida, Gainesville, FL, USA
Abstract
Improvements in high-throughput sequencing technologies have spurred a large number of studies aimed at obtaining a better under-
standing of the composition and the dynamics in gut microbiota and its associations with various human diseases, especially those in the
intestinal tract. Here we brieﬂy summarize results from three different such studies from our group, all of which used 454 based high-
throughput 16S rRNA sequence analysis combined with other microbiota proﬁling methods to determine faecal microbiota composi-
tion. In the ﬁrst study, a controlled feeding trial, we establish that energy gain from the consumption of up to 50 g/day of a resistant
maltodextrin depends on the prevalent microbiota composition. Over time, resistant maltodextrin supplementation increased the pro-
portion of total faecal bacteria as well as potentially beneﬁcial biﬁdobacteria. Thus, energy gain from resistant maltodextrin in an individ-
ual appears to vary over time and depend on the adaptation of gut microbiota. We then illustrate the power of molecular tools for
identifying (i) distortions in early microbiota development in pre-term infants and the presence of potentially novel pathogens contribut-
ing to necrotizing enterocolitis and (ii) a speciﬁc microbiota signature, based on discriminant analysis of the 16S rRNA sequences, that
correlates with the prevalence of an early risk marker associated with colorectal carcinogenesis, intestinal adenoma, in elderly adults.
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Introduction
The role of host-associated microbiota, especially those
residing in the intestinal tract, has received renewed interest
for potential associations with human health. Molecular 16S
rRNA based tools have long helped to overcome earlier limi-
tations of conventional microbiological plating methods in
studying gut microbiota composition [1,2]. More recently,
the developments of high-throughput parallel sequencing
methodologies have increased our ability to analyse microbi-
ota at a previously unimaginable depth. These tools have
sparked novel microbiota research including suggestions of
associations between the proportion of Bacteroidetes and
obesity [3–5]. Although it appears clear from multiple studies
that obesity status is associated with prevalent microbiota
composition, at least in humans the evidence that gut
microbes signiﬁcantly contribute to the development of
obesity needs further investigation. Gut microbes can con-
tribute to obesity by two major means. First, they can gener-
ate additional energy in the form of short chain fatty acids
from substrates, such as dietary ﬁbre, that reach the large
colon. Second, they can affect obesity-associated pathways in
the host through signalling, such as the upregulation of Fiaf
[6] in response to gut microbes. We present below data sug-
gesting that energy gain from resistant maltodextrin (RM) is
dependent on resident gut microbes and conversely that RM
shapes microbiota composition.
Due to extensive research funding that recently became
available in the USA through the National Institutes of
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Health Human Microbiome Project, and similar projects in
other regions of the world, there has been an explosion in
the number of studies that evaluate associations between
microbiota and various disease states. Early results from
many of these studies suggest that microbiota is affected by
a variety of diseases, but the cross-sectional character of
many studies is not well suited for determining associations
with disease aetiology. We present below early data from a
prospective cohort study in pre-term infants that allowed us
to investigate in detail the potential contributions of a distor-
tion in early microbiota development and the presence of
novel pathogens to the development of necrotizing entero-
colitis (NEC). We then summarize ﬁndings from a colonos-
copy screening study in adults that shows the utility of
advanced 16S rRNA data mining tools [7] to reveal a micro-
biota signature pattern associated with the prevalence of
colorectal polyps. All three studies were approved by the
appropriate institutional review boards. Our ﬁndings illus-
trate the need for (i) well controlled feeding studies to link
speciﬁc dietary components to changes in microbiota
composition, and (ii) prospective cohort studies to establish
causal links between microbiota and human disease states.
Resistant maltodextrin feeding study
While the amounts of energy derived from consuming fats,
proteins and digestible carbohydrates are well established,
the metabolizable energy and net energy value associated
with the consumption of dietary ﬁbre has been less studied
[8]. RM is a soluble non-viscous dietary ﬁbre that, although
recalcitrant to human digestive enzymes, is a substrate for
fermentation by the commensal microbiota, primarily that of
the large intestine. Due to the chemical composition of RM,
determination of its ﬁbre content requires a speciﬁc analyti-
cal method [9]. We performed a human feeding study to
determine if energy gain from increased dietary intake of RM
was dependent on resident gut microbiota, and if microbiota
adapted to increased RM by increasing microbes that can uti-
lize this speciﬁc dietary ﬁbre.
In a randomized, controlled dose–response study 14
healthy males were assigned to a random treatment
sequence that consisted of three 28-day treatment periods
separated by a wash-out period of at least 14 days, with con-
trolled diets: a placebo diet (0 g/day RM + 50 g/day maltod-
extrin) and two levels of dietary RM (25 g/day RM + 25 g/day
maltodextrin and 50 g/day RM + 0 g/day maltodextrin).
When the energy value of RM was calculated by bomb calo-
rimetry for each individual, we detected a wide range among
individuals, from 0 to 4 kcal/g with a mean of 2.2 kcal/g. We
hypothesized that differences in microbial composition and
associated activities caused these differences in energy value
for RM. Microbiota composition was determined using a
comprehensive 16S rRNA based approach that included
denaturing gradient gel electrophoresis (DGGE) for initial
proﬁling and quality control, qPCR and ﬂuorescent in situ
hybridization for targeted quantiﬁcation and 454 based 16S
rRNA sequencing. DGGE indicated that a particular bacterial
signature (band) increased upon RM supplementation. Puriﬁ-
cation and sequencing of the respective band suggested that
bacteria grouping closest to Lachnospiraceae increased with
RM. No consistent effects of RM were detected when faecal
samples from four individuals were submitted to deep 16S
rRNA sequencing. Total numbers of bacteria per gram of
faeces increased by 22% in subjects consuming 50 g/day RM
(p 0.02). While overall microbiota diversity was little
affected, the numbers of biﬁdobacteria increased during RM
periods (qPCR, p 0.03) (Fig. 1). Differences in microbiota
composition, speciﬁcally higher numbers of biﬁdobacteria in
the group gaining more energy, correlated with the varia-
tions in energy gain from RM intake. Our ﬁndings are consis-
tent with the hypothesis that energy gain from ﬁbre that
reaches the large intestine varies between individuals and is
dependent on the resident gut microbiota. The intake of RM
microbiota changed the microbiota in individuals, probably
towards a composition more adapted to utilizing the addi-
tional dietary ﬁbre. This observation suggests that as the
microbiota adapts energy gain from ﬁbre, it is changing over
time even within an individual.
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FIG. 1. Change in biﬁdobacteria by qPCR. The number of genome
equivalents for biﬁdobacteria per nanogram of input DNA are shown
for days 1 and 24 during the placebo and the period with 50 g/day
of resistant maltodextrin (RM50). p-values are indicated within the
intervention periods.
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Microbiota and necrotizing enterocolitis in
pre-term infants
Pre-term infants are at an increased risk for developing a
variety of perinatal diseases. NEC is a severe disease mostly
observed in pre-term infants; almost 5000 NEC cases are
identiﬁed each year in the USA alone with a mortality rate
of 15–30%. The disease can leave surviving infants with long-
term health problems and is a large burden on the health-
care system. NEC is an inﬂammatory disease of the bowel
with a diffuse disease presentation [10]. Our earlier studies
evaluated microbiota composition in pre-term infants [11].
We are currently performing a prospective cohort study in
infants delivered at a gestational age of 32 weeks or younger
with a birth weight of 1250 g or less at three hospitals
(Gainesville and Jacksonville, FL, USA). In a preliminary analy-
sis we matched nine NEC cases identiﬁed by a neonatolo-
gist, using modiﬁed Bell’s criteria phase II and III, with nine
controls by gestational age, birth weight, date and centre.
We analysed microbiota in faecal samples collected from
cases 1–2 weeks before and during the week of diagnosis
and in gestational age matched samples from controls. Initial
DGGE proﬁling did not indicate the presence of distinct
molecular signatures in cases either before or during the
week of NEC diagnosis. However, an extensive 454 based
16S rRNA analysis suggested that at the time point before
NEC diagnosis the proportion of Proteobacteria, Actinobac-
teria and Bacteriodetes was lower in cases than in controls
[12???]. Based on Unifrac analysis there appeared to be more
heterogeneity in microbiota composition before NEC diag-
nosis among cases compared with controls. Overall diversity
did not differ between cases and controls [12]. At the pre-
diagnosis time point the proportion of Firmicutes was higher
in cases (61%) than in controls (31.5%). During the week of
diagnosis we observed a bloom in Proteobacteria (from 36%
to 71%) in cases only; their Proteobacteria proportion was
now higher than that in controls (71% vs 56%) while Firmi-
cutes decreased (61–29%). Actinobacteria and Bacteriodetes
remained low in cases (<1%). When we analysed speciﬁc
operational taxonomic units (OTUs) we detected 11 OTUs
exclusively in cases during the week of NEC diagnosis but
not 2 weeks before and not in controls. These OTUs
grouped to various known Proteobacteria and other known
pathogens, but some represented ‘unknowns’ grouping to
c-Proteobacteria, a group of bacteria that contains many
established enteric pathogens. Our ﬁndings suggest an asso-
ciation between a lack of early colonization and a later
bloom of Proteobacteria and NEC. Furthermore, molecular
signatures suggest that currently unknown pathogens
grouping closest to c-Proteobacteria might contribute to
NEC in a subset of pre-term infants. These still speculative
ﬁndings need to be corroborated in more cases from our
and other ongoing studies in pre-term infants.
Gut microbiota and colorectal
carcinogenesis
We have previously shown evidence from a study in APCMin
mice that caloric restriction, diet composition and exercise
affect both intestinal microbiota composition and polyp num-
bers [13]. Some bacterial signatures appeared to be associ-
ated with reduced intestinal carcinogenesis in that mouse
model, indicating that the physiological conditions in the gut
of mice with multiple polyps might vary from those in
‘healthy’ mice, probably affecting microbiota composition.
We have further shown in four individuals undergoing a
screening colonoscopy that microbiota composition after a
colonoscopy procedure differs from that before for up to
4 weeks [14]. In another study we established that microbi-
ota composition correlates with dietary habits and differs
between African Americans (AA) and Caucasian Americans
(CA) [15]. AA suffer from an increased risk of colorectal
cancer (CRC). Thus, correlating dietary habits in AA with
microbiota composition and markers of colorectal carcino-
genesis might help to identify targets for a microbiota-
directed prevention regimen to reduce their disease burden.
Colorectal carcinogenesis is a long process that involves mul-
tiple mutations that probably affect gut physiology [16]. At
the time that CRC is symptomatic the physiological condi-
tions in the gut have changed and the microbiota has proba-
bly adapted to those conditions. Thus, analysis of microbiota
of subjects that already suffer from CRC is unlikely to
identify many microbes that contributed to the onset of the
disease. In contrast, an analysis of microbiota in subjects
with early lesions, small to medium sized adenomas that are
unlikely to have a large effect on gut physiology, might be
better suited for identifying contributions of microbiota to
the development of CRC. Ideally, a prospective study
design should be performed to follow changes in micro-
biota in a large number of subjects and identify what changes
in microbiota occur at the earlier stages of colorectal
carcinogenesis.
We have recently collected pre-colonoscopy stool sam-
ples as well as biopsy samples taken during the procedure in
more than 100 individuals to determine if a microbial signa-
ture proﬁle is associated with an individual’s risk of harbour-
ing at least one adenoma and if such signature is stronger in
subjects with high risk adenomas. We selected 30 cases with
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at least one adenoma and compared their microbiota to that
in 30 matched controls (age, gender, body mass index cate-
gory). In our studies we deﬁned subjects to be at high risk if
they had multiple polyps or at least one polyp larger than
5 mm. Using 454 based 16S rRNA analysis we initially deter-
mined that microbiota in biopsy samples differs from that in
stool samples (Fig. 2). Thus, microbiota samples from biop-
sies need to be analysed separately from faecal samples.
When evaluating overall microbiota composition, using Uni-
frac analysis of >250 000 sequence reads (average length 214
nucleotides), we did not detect any pattern that allowed us
to differentiate subjects by case status (polyp/no polyp) or
race (AA/CA) in either stool or biopsy sample. We did,
however, detect many operational taxonomic levels (98%
similarity) in which prevalence differed by case or race. The
fold differences were larger when we compared microbiota
in controls with high risk cases rather than all cases. This
observation is encouraging as it suggests that there are more
dramatic differences in subjects with high risk lesions, which
more strongly correlate with CRC. Because we performed
these analyses on a few thousand OTUs most ﬁndings are
probably false positives. We are currently working on devel-
oping the appropriate statistics for such analyses that appro-
priately correct for the multiple analyses performed. We
then used a novel discriminant analysis [7] to develop a
microbial pattern that can distinguish microbiota in the
stools of cases from that in matched controls. At a level of
0.08 sequence dissimilarity we detected a microbiota pattern
based on 27 OTUs that allowed for a distinction between
cases and controls with a high correlation (area under the
curve 0.81).
Conclusions
Our studies are consistent with the hypothesis that diet,
particularly dietary ﬁbres that reach the colon, can affect
microbiota composition. Energy gain from dietary ﬁbre var-
ies between individuals as well as within an individual over
time. Microbiota pattern as well as signature sequences
appear to be associated with NEC and colorectal polyp
prevalence. A prospective study design appears necessary
to determine if microbiota contributes to the aetiology of
various diseases. Such studies should now be developed to
allow us to determine within the next decade(s) if and
how microbiota affects human health. Once we have a
thorough understanding of causative associations, micro-
biota-based diagnostics and a preventive regimen can be
developed that might extend healthy life years and reduce
the burden of various diseases.
Acknowledgements
The RM studies were funded by the US Department of Agri-
culture and the Matsutani Chemical Industry Co. Ltd. The
ongoing pre-term infant study is funded by a grant from the
NIH RO1 HD 059143 to Dr J. Neu. and Dr V. Mai was
funded by a mentored research scholar award from the
American Cancer Society (MRSGT CCE-107301) for the col-
onoscopy study. Work on bioinformatics for 16S rRNA
sequence analysis is funded by NSF grant DBI-1062362 to
Drs Sun and Mai.
Transparency Declaration
D. Baer, D. Gordon and V. Mai received funding and/or
consulted for Matsutani Chemical industry Co. Ltd. S.
Kanahori is an employee of Matsutani Chemical industry Co.
Ltd. J. Neu and V. Mai are funded by an NIH grant. V. Mai
also received funding from the American Cancer Society.
J. Valentine received funding from NIH. T. Culpepper, X.
Wang and M. Ukhanova have no conﬂicts of interest.
FIG. 2. Unifrac based analysis of microbiota composition in biopsy
and stool samples. Principal components analysis plot based on
weighted Unifrac analysis based on 454 16S rRNA sequences from
biopsies (squares) and stool samples (circles) in the colonoscopy
study.
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